Role of Gut Microbiome in Neurodegenerative Disorders provides an overview of the gut microbiota and its interactions with the gut and the central nervous system. This book reviews the relevance of this axis to the pathogenesis of neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), and Multiple sclerosis (MS). Various chapters discuss the effects of gut derived particles in various parts of brain and the targeting pathways leading to protein deposition in brain.
Role of Gut Microbiome in Neurodegenerative Disorders provides an overview of the gut microbiota and its interactions with the gut and the central nervous system. This book reviews the relevance of this axis to the pathogenesis of neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), and Multiple sclerosis (MS). Various chapters discuss the effects of gut derived particles in various parts of brain and the targeting pathways leading to protein deposition in brain.
1. Overview of Neurodegenerative Disorders 2. Gut Microbiota and Neurological Diseases 3. Gut-Brain Axis 4. Gut-Brain Axis in Neurological Diseases 5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders 6. Gut Metabolites in Neurodegenerative Diseases 7. Influence of Gut Microbiota on Cerebellum 8. Influence of Gut Microbiota on Hippocampus 9. Influence of Gut Microbiota on Axonal Cells of the brain 10. Mechanistic action of Gut Microbiota on Glial cells 11. Gut as a second brain- Largest producer of serotonin 12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders 13. Gut metabolites - effective biomarker for Neurodegenerative disorder 14. Protocol - Isolation of Gut Microbiome from Faecal sample 15. Gut metabolites isolation from Blood 16. Metagenomics and sequence analysis 17. Computer aided detection method 18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders 19. Dietary and Gut microbiome 20. Ongoing clinical trials 21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota 22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders
1. Overview of Neurodegenerative Disorders 2. Gut Microbiota and Neurological Diseases 3. Gut-Brain Axis 4. Gut-Brain Axis in Neurological Diseases 5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders 6. Gut Metabolites in Neurodegenerative Diseases 7. Influence of Gut Microbiota on Cerebellum 8. Influence of Gut Microbiota on Hippocampus 9. Influence of Gut Microbiota on Axonal Cells of the brain 10. Mechanistic action of Gut Microbiota on Glial cells 11. Gut as a second brain- Largest producer of serotonin 12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders 13. Gut metabolites - effective biomarker for Neurodegenerative disorder 14. Protocol - Isolation of Gut Microbiome from Faecal sample 15. Gut metabolites isolation from Blood 16. Metagenomics and sequence analysis 17. Computer aided detection method 18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders 19. Dietary and Gut microbiome 20. Ongoing clinical trials 21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota 22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
